Tikvah Management’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-5,901,855
Closed -$14.9M 24
2023
Q4
$14.9M Buy
5,901,855
+686,115
+13% +$1.6M 5.12% 10
2023
Q3
$12.5M Hold
5,215,740
4.47% 10
2023
Q2
$12M Buy
5,215,740
+1,001,000
+24% +$2.83M 4.1% 11
2023
Q1
$10.7M Hold
4,214,740
4.42% 8
2022
Q4
$10.6M Buy
4,214,740
+830,000
+25% +$2.32M 5.05% 6
2022
Q3
$9.82M Buy
3,384,740
+532,000
+19% +$2.24M 4.54% 7
2022
Q2
$12.9M Buy
2,852,740
+298,500
+12% +$1.78M 5.56% 6
2022
Q1
$20.5M Buy
2,554,240
+984,200
+63% +$8.68M 6.55% 5
2021
Q4
$18.3M Buy
1,570,040
+406,848
+35% +$4.87M 5.1% 6
2021
Q3
$14.4M Buy
+1,163,192
New +$13.1M 3.9% 10

Tikvah Management's SLGC Position: Q1 2024 in Review

Tikvah Management sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q1 2024, closing a stake of 5,901,855 shares — an estimated $14.9M sold.

Tikvah Management first reported a position in SLGC in Q3 2021 and held it in 10 quarters. The position peaked at $20.5M in Q1 2022. 0 funds tracked by Wall St. Rank hold SLGC as of Q1 2024.

  • Tikvah Management reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
  • Tikvah Management sold 5,901,855 SomaLogic, Inc. Class A Common Stock shares in Q1 2024, an estimated $14.9M.
  • Tikvah Management first reported a position in SomaLogic, Inc. Class A Common Stock in Q3 2021 and held it in 10 quarters.
  • Tikvah Management's SomaLogic, Inc. Class A Common Stock position peaked at $20.5M in Q1 2022.
  • 0 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q1 2024.

Based on Tikvah Management's 13F filing for Q1 2024, filed 15 May 2024.